Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
ARIAD is engaged in the discovery and development of breakthrough medicines to treat cancer by regulating cell signaling with small molecules. The Company is developing a comprehensive approach to patients with cancer that addresses the greatest medical need – aggressive and advanced-stage cancers for which current treatments are inadequate. Medinol Ltd. also is developing stents and other medical devices that deliver ARIAD’s lead cancer product candidate to prevent reblockage at sites of vascular injury following stent-assisted ( www.ariad.com )
ARIAD Pharmaceuticals , Inc.
26 Landsdowne Street
Cambridge, Massachusetts 02139
USA
Tel: (617) 434-0400
Fax: (617) 494-8144